Rob Zenilman submits: Year over year quarterly revenue growth of stocks covered in the Biotech sector ranged from 1,832.1% (AMLN) down to -3.4% (MEDI), with a median value of 33.3%.
* View More Biotech Sector Charts *
Data in table version -- click on a ticker for
opinion and analysis of the company:
|
|
|
Quarter
|
Revenue
|
Last Yr.
|
YOY
|
| Ticker
|
Company
|
Ending
|
$(mm)
|
($mm)
|
Increase%
|
| AFFX | Affymetrix Inc. | 03/31/06 | $86.39 | $88.62 |
-2.5%
| | ALXN | Alexion Pharmaceuticals I | 03/31/06 | $0.77 | $0.57 |
35.9%
| | AMGN | Amgen Inc. | 03/31/06 | $3,127.00 | $2,735.00 |
14.3%
| | AMLN | Amylin Pharmaceuticals In | 03/31/06 | $82.35 | $4.26 |
1,832.1%
| | BIIB | Biogen Idec Inc. | 03/31/06 | $427.80 | $427.35 |
0.1%
| | BMRN | BioMarin Pharmaceutical I | 03/31/06 | $13.81 | $4.99 |
176.8%
| | BSTE | Biosite Incorporated | 03/31/06 | $79.33 | $71.85 |
10.4%
| | CELG | Celgene Corporation | 03/31/06 | $181.84 | $112.40 |
61.8%
| | DNA | Genentech Inc. | 03/31/06 | $1,986.00 | $1,462.00 |
35.8%
| | ELN | Elan Corp. plc | 03/31/06 | $134.30 | $102.70 |
30.8%
| | GILD | Gilead Sciences Inc. | 03/31/06 | $692.88 | $430.41 |
61.0%
| | GPRO | Gen-Probe Inc. | 03/31/06 | $86.26 | $68.83 |
25.3%
| | IMCL | Imclone Systems Inc. | 03/31/06 | $245.13 | $85.77 |
185.8%
| | INCY | Incyte Corp. | 03/31/06 | $6.47 | $2.92 |
121.8%
| | ISTA | ISTA Pharmaceuticals Inc. | 03/31/06 | $5.55 | $0.58 |
856.6%
| | KOSP | KOS Pharmaceuticals Inc. | 03/31/06 | $170.77 | $153.29 |
11.4%
| | MEDI | MedImmune Inc. | 03/31/06 | $491.60 | $508.70 |
-3.4%
| | NABI | Nabi Biopharmaceuticals | 04/01/06 | $27.55 | $26.08 |
5.6%
| | NBIX | Neurocrine Biosciences In | 03/31/06 | $11.24 | $10.86 |
3.4%
| | ONXX | Onyx Pharmaceuticals Inc. | 03/31/06 | N/A | $1.00 |
N/A
| | PGNX | Progenics Pharmaceuticals | 03/31/06 | $11.00 | $2.59 |
324.9%
| | PHRM | Pharmion Corp. | 03/31/06 | $56.59 | $51.74 |
9.4%
| | TELK | Telik Inc. | 03/31/06 | N/A | $0.02 |
N/A
| | VRTX | Vertex Pharmaceuticals In | 03/31/06 | $39.09 | $28.61 |
36.6%
|
Data: CapitalIQ
Note: Quarterly data is the most recently reported fiscal quarter as of July 6, 2006 vs. the same period last year.
Related:
- Most recent opinion and analysis of Biotech stocks
-
Full transcripts of recent conference calls in the Biotech sector
-
Add the Biotech Stock Blog to your My Yahoo! page
Aside: Did you know that Seeking Alpha now publishes a one-page recap of Jim Cramer's Mad Money TV show, Lightning Round, Radio program and Stop Trading?
Related Articles
-
How Majesco Helped Me Win with Insmed: Lessons in Speculative Investing
Quick Read
Jul 09, 2009
-
FDA Calendar Updates: Rigel Pharma, GlaxoSmithKline, Eisai, SuperGen
Quick Read
Jul 09, 2009
-
Amgen May Have a Winner on Its Hands
Quick Read
Jul 09, 2009
-
Amgen's D-mab Debate
Quick Read
Jul 09, 2009
-
FDA Calendar Updates: Amgen, Bayer, Biogen, Noveko, Peplin, Transdel
Quick Read
Jul 09, 2009
|
|